Beauty
“A 2025 systematic review and meta-analysis of 23 randomised trials (1,474 people) found that high-quality studies showed no significant effect of collagen supplements on skin hydration, elasticity, or wrinkles, while low-quality, industry-funded studies reported benefits.”
Plain restatementA 2025 systematic review and meta-analysis pooling 23 randomised controlled trials with 1,474 participants reported that, in subgroup analyses, trials rated high quality found no statistically significant effect of oral collagen supplementation on skin hydration, elasticity or wrinkles, while trials rated low quality and those funded by industry reported significant benefits.
This one checks out on the facts, with one important piece left out. The study is real: a 2025 review in The American Journal of Medicine pooled 23 randomised trials with 1,474 people, and it did report that trials rated highest quality, and trials without industry funding, showed no significant effect on skin hydration, elasticity or wrinkles, while industry-funded and lower-rated trials reported benefits. What the post's headline sentence leaves out is that when all 23 trials were pooled together, the result was positive for all three measures. The null findings appear only once the authors split the set. Worth knowing too that "high quality" here meant a perfect 5 out of 5 on a 5-point scale in a set averaging 4.22, so the bar was narrow, and that a larger 2026 review covering 113 trials and nearly 8,000 people did find improvements in skin elasticity and hydration while finding no clear effect on wrinkles. The two reviews genuinely disagree and that disagreement has not been resolved. This is general information only and not medical or dermatological advice.
A 2025 systematic review and meta-analysis [drifted from the evidence:] of 23 randomised trials (1,474 [drifted from the evidence:] people) found that [drifted from the evidence:] high-quality studies showed no significant effect of collagen [drifted from the evidence:] supplements on skin hydration, elasticity, or wrinkles, while [drifted from the evidence:] low-quality, industry-funded studies reported benefits.
A 2025 systematic review and meta-analysis [added by the neutral restatement:] pooling 23 randomised [added by the neutral restatement:] controlled trials [added by the neutral restatement:] with 1,474 [added by the neutral restatement:] participants reported that, [added by the neutral restatement:] in subgroup analyses, trials rated high quality found no [added by the neutral restatement:] statistically significant effect of [added by the neutral restatement:] oral collagen [added by the neutral restatement:] supplementation on skin hydration, elasticity or wrinkles, while [added by the neutral restatement:] trials rated low quality and those funded by industry reported [added by the neutral restatement:] significant benefits.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- The paper exists and is correctly identified by year and design. Myung and Park published a systematic review and meta-analysis in The American Journal of Medicine in 2025.
- The two numbers are exact. 23 RCTs and 1,474 participants is what the abstract reports.
- The high-quality subgroup finding is reported as the claim states. When only higher-quality studies were considered, no significant impact was observed across hydration, elasticity or wrinkles.
- The funding-source split is reported as the claim states. Trials without pharmaceutical company funding showed no effect on the three outcomes, while trials with such funding did.
- Treating quality and funding together is something the authors themselves did, not an invention of the post. The methods describe a combination of methodological quality and funding status, high-quality and not funded versus low-quality and funded.
- The post's own image text, which says some formulations show modest gains and that dramatic reversal is not supported, is consistent with the wider literature, including the 2026 umbrella review's finding of improvement in elasticity and hydration but not an end to wrinkles.
- The claim sentence reports only the subgroup results and leaves out the paper's own headline pooled result. Across all 23 trials together, the supplements significantly improved skin hydration, elasticity, and wrinkles. A reader who sees only the subgroup half would not know that the main analysis was positive and that the null findings emerge when the set is split. The post's caption partly repairs this by mentioning modest gains in individual trials, but the claim as written does not.
- "High-quality" sounds like a settled grade and is not. In this paper it meant a perfect 5 out of 5 on the Jadad scale, against a set whose average score was 4.22, so most trials in the pool were close to the cut-off and fell on the "low-quality" side of it. That is a narrow and paper-specific threshold, not a general judgement that those trials were poor.
- The claim compresses "low-quality" and "industry-funded" into one group, as if the benefit-reporting trials were all both. The paper ran these as separate subgroups as well as a combined one, and trade bodies responding to the paper argue that the majority of the industry-funded studies scored 3 to 5 out of 5 on the Jadad scale. Those are interested parties and their objections are context rather than evidence, but the point that the two labels are not interchangeable stands on the paper's own methods.
- Presented in October 2026 with no date framing beyond "2025," the claim reads as the current state of the evidence. It is not the most recent or the largest synthesis. The 2026 umbrella review covering 16 systematic reviews, 113 randomised controlled trials and almost 8,000 participants reports improvements in elasticity and hydration.
- The exact effect sizes and confidence intervals within the high-quality subgroup, and how many of the 23 trials fell into it, could not be confirmed from the abstract and PDF excerpts available. A null result in a small subgroup can reflect too few participants rather than a true absence of effect, and without those numbers that distinction cannot be settled here.
- Whether the funding classifications Myung and Park assigned to individual trials are correct is contested. The challenges come from collagen industry bodies, so they carry an obvious interest, and no independent re-analysis correcting or confirming the classifications was found.
- The two syntheses disagree and the reason is not resolved. The 2025 paper splits by quality and funding and finds nulls; the 2026 umbrella review pools published meta-analyses and finds benefit. Pooling meta-analyses can carry forward the same biased trials the 2025 paper was trying to filter out, and the 2026 hydration estimate came with heterogeneity of 90.4 percent, meaning the trials disagree with each other a great deal.
- Dose and formulation are not pinned down anywhere in the claim. Collagen supplements differ widely in peptide source, molecular weight, dose and added ingredients such as vitamin C and hyaluronic acid, and a pooled figure across that mixture does not tell a reader what any specific product does.
The paper described in the claim exists and the numbers match. The abstract states that a total of 23 RCTs with 1474 participants were analyzed, and that in a meta-analysis of all 23 RCTs, collagen supplements significantly improved skin hydration, elasticity, and wrinkles. It then reports that in the subgroup meta-analysis by funding source, studies not receiving funding from pharmaceutical companies revealed no effect of collagen supplements for improving skin hydration, elasticity, and wrinkles, while those receiving such funding did. On the quality axis, the published PDF states that in the subgroup meta-analysis by methodological quality, high-quality studies revealed no significant effect. Trade coverage of the paper summarises the same two subgroup findings, reporting that trials not funded by pharmaceutical or supplement companies showed no benefit while those with industry backing reported positive effects, and that when only higher-quality studies were considered, no significant impact was observed across hydration, elasticity or wrinkles. The authors' stated conclusion is blunt: there is currently no clinical evidence to support the use of collagen supplements to prevent or treat skin aging. On how quality was defined, the paper's methods say the grouping rested on the RoB 2 or Jadad scale, and a combination of methodological quality and funding status, high-quality and not funded versus low-quality and funded, and that studies scoring 5 on the five-point Jadad scale were considered high-quality and the remaining studies were classified as low-quality, as the average score across all included studies was 4.22. The paper itself declared Funding: None and no conflict of interest for either author. Later and larger syntheses reach a different headline. A 2026 umbrella review from Anglia Ruskin University brings together evidence from 16 systematic reviews, 113 randomised controlled trials and almost 8,000 participants around the world, and reported noted improvements in skin elasticity rated high certainty, SMD 1.01, 95% CI 0.44 to 1.59, across 1217 participants. Press coverage of that review reports that collagen supplements can improve skin elasticity and hydration when taken consistently over time but do not stop wrinkles. A separate 2026 meta-analysis found oral collagen supplementation improved skin hydration, SMD 0.71, 95% CI 0.08 to 1.34, and elasticity, with very high statistical heterogeneity of 90.4 percent.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.
Compact share page: beauty.trueseeker.com/s/cdc57094be25/6LDK5mxcuRbFd8mjSNeGukW
Ask this case
Answers come only from the case file above; nothing is added.
Is it true that the 2025 review found no effect of collagen on skin, as the claim says?
That is true only for the subgroup of trials rated high quality or free of industry funding. When all 23 trials were pooled together, the same review actually found collagen significantly improved skin hydration, elasticity, and wrinkles, which the claim leaves out.
What did the 2025 study actually look at?
It was a systematic review and meta-analysis by Myung and Park, published in The American Journal of Medicine in 2025, pooling 23 randomised controlled trials with 1,474 participants.
What does 'high quality' mean in this study?
It meant a trial scored a perfect 5 out of 5 on the Jadad scale. Since the average score across all included studies was 4.22, most trials fell just short of that cutoff and were classified as low quality, so the bar was narrow and specific to this paper.
Does this mean collagen supplements definitely do not work?
No. A larger 2026 review covering 113 trials and almost 8,000 participants found improvements in skin elasticity and hydration, though no clear effect on wrinkles. The two reviews disagree and this disagreement has not been resolved.
Are the industry-funded studies definitely low quality?
Not necessarily. The paper treated quality and funding as related but separate categories, and collagen industry bodies have argued that most of the industry-funded studies actually scored 3 to 5 out of 5 on the Jadad scale. No independent re-analysis confirming or correcting this was found.